All In MedTech

FDA Clearance Tracker · P200046-S023

Harmony™ TPV System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 3, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 3, 2023

Approved

Time to decision

28 days

Received Oct 6, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P200046-S023
Device name
Harmony™ TPV System
Applicant location
Santa Rosa, CA
Received
Oct 6, 2023
Decided
Nov 3, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P200046

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the post-approval study PAS001. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P200046.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.